Skip to content

The effect of Momordica charantia supplementation on blood glucose levels

The effect of Momordica charantia supplementation on blood glucose levels - Bitter-sweet

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON48458
Enrollment
30
Registered
2019-08-21
Start date
2019-09-17
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

blood glucose glucose tolerance

Interventions

4-week intervention with 2.4g/d dried bitter-gourd supplements and a reference intervention with 2.4g/d dried cucumber supplements.

Sponsors

Wageningen Universiteit
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: age 50-75yrs BMI >25 kg/m2 Having veins suitable for blood sampling via a catheter (judged by study nurse/medical doctor) Having one or more of the following criteria: o HbA1c >5.7% o fasting glucose >5.6mmol/L o two-hour glucose levels >7.8 mmol/L on the 75-g oral glucose tolerance test .

Exclusion criteria

Exclusion criteria: * History of gastro-intestinal surgery or having (serious) gastro-intestinal complaints * History of liver dysfunction (cirrhosis, hepatitis) or liver surgery * Kidney dysfunction (self-reported) * Use of medication/supplements that may influence the study results, such as medicines known to interfere with glucose homeostasis (judged by medical doctor) * Anaemia (Hb values 5 kg in the month prior to pre-study screening * Not willing to give up blood donation during the study * Current smokers * Alcohol intake *4 glasses of alcoholic beverages per day * Abuse of illicit drugs * Food allergies for products that we use in the study * Participation in another clinical trial at the same time * Being an employee of the Food, Health & Consumer Research group of Wageningen Food & Biobased Research or dept. human nutrition and health of Wageningen University.

Design outcomes

Primary

MeasureTime frame
fasting levels of plasma glucose and 2hour plasma glucose after a 75-gram OGTT.

Secondary

MeasureTime frame
HbA1c, fructosamine, insulin (fasting and in response to a 75-OGTT). From the fasting glucose and insulin values we will calculate HOMA-IR score. We will also measure glucose responses during a three day controlled dietary period.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)